Pimavanserin Tartrate 34 Mg ORAL CAPSULE [NUPLAZID]
8449
Phase 2 small_molecule active
Quick answer
Pimavanserin Tartrate 34 Mg ORAL CAPSULE [NUPLAZID] for Autism Spectrum Disorder is a Phase 2 program (small_molecule) at ACADIA PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ACADIA PHARMACEUTICALS INC
- Indication
- Autism Spectrum Disorder
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active